Canada Communicable Disease Report (CCDR)

CCDR

Coming in 2027: A new scientific journal

The Public Health Agency of Canada will launch a new scientific journal offering a single, comprehensive platform that will showcase the full spectrum of public health research, including health promotion and chronic and communicable disease prevention and control. The new journal is anticipated to launch in spring 2027 and will begin accepting new manuscripts at that time. The first issue is currently planned for late 2027. More information will be available in the coming months!

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. Learn more about CCDR.

Latest issue: Volume 52-6, June 2026: Optimal Timing of Seasonal Vaccination

Advisory Committee Statement

Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance to protect infants and children from respiratory syncytial virus disease
A Killikelly, W Siu, N Brousseau on behalf of the National Advisory Committee on Immunization (NACI)

Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on respiratory syncytial virus (RSV) vaccines for older adults and for adults at high risk of severe RSV disease
J Zafack, EM Abrams, N Brousseau on behalf of the National Advisory Committee on Immunization (NACI)

Scoping Review

Intraseasonal waning of influenza vaccine effectiveness and implications for the optimal timing of seasonal vaccination programs: A scoping review
P Doyon-Plourde, F Tadount, A Gil, C Lazarescu, M-M Ursu, N Sicard, W Siu, A Sinilaité

Modelling Study

Economic evaluation of wastewater surveillance in Ontario, Canada, using COVID-19 as a case study
Y Sahakyan, D Champredon, P Rabeenthira, A Rodriguez  Barizonte, M Fleury, B Sander

Outbreak Report

Mycobacterium abscessus soft tissue infections associated with subcutaneous injection of lipolytic agents: An outbreak report and novel molecular epidemiology analysis approach
X Quan-Nguyen, N Waglechner, M Veillette, P-A Vasil, F Point, B Tannir, M Zarandi-Nowroozi, C Tsimiklis, N Pétrin, M Teltscher, A Urbanek, P-M Akochy, J Cox, R Lee, S Grandjean Lapierre

Epidemiological Study

Characteristics of outpatient nirmatrelvir/ritonavir recipients during the 2022/2023 era in Alberta, Canada: A retrospective observational population-based study
K Vu, J Randall, K Martins, S Aponte-Hao, L Saxinger, J Leal, E Rennert-May, E Rafferty, P Uyen Nguyen, T Williamson, S Klarenbach

Recent Issues

Threat Assessment in Public Health

Threat Assessment in Public Health – May 2026

Threat Assessment in Public Health in Canada

Language & the Web: Tools for Communication, Education & Health Equity

Language & the Web: Tools for Communication, Education & Health Equity – April 2026

Language & the Web: Tools for Communication, Education & Health Equity in Canada

Implementation Science

Vaccine Safety: Uptake and Hesitancy – March 2026

Vaccine Safety: Uptake and Hesitancy in Canada

Page details

2026-06-24